Boostrix: Phase III data

In an observer-blind, U.S. Phase III trial in 4,114 healthy subjects aged

Read the full 121 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE